Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-002862
Filing Date
2022-03-10
Accepted
2022-03-10 20:36:42
Documents
1
Period of Report
2022-03-08

Document Format Files

Seq Description Document Type Size
1 form4-03102022_050332.html 4  
1 form4-03102022_050332.xml 4 12996
  Complete submission text file 0001415889-22-002862.txt   14418
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Issuer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904
Business Address
Riebman Jerome (Reporting) CIK: 0001825821 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39577 | Film No.: 22730880